Eltrombopag, low‐dose rituximab, and dexamethasone combination as frontline treatment of newly diagnosed immune thrombocytopaenia
Main Authors: | , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
2019
|
Online Access: | http://eprints.uanl.mx/15810/1/12.pdf |
_version_ | 1824414388477493248 |
---|---|
author | Gómez Almaguer, David Colunga Pedraza, Perla Rocío Gómez de León, Andrés Gutiérrez Aguirre, César Homero Cantú Rodríguez, Olga Graciela Jaime Pérez, José Carlos |
author_facet | Gómez Almaguer, David Colunga Pedraza, Perla Rocío Gómez de León, Andrés Gutiérrez Aguirre, César Homero Cantú Rodríguez, Olga Graciela Jaime Pérez, José Carlos |
author_sort | Gómez Almaguer, David |
collection | Repositorio Institucional |
format | Article |
id | eprints-15810 |
institution | UANL |
language | English |
publishDate | 2019 |
record_format | eprints |
spelling | eprints-158102022-04-08T23:28:45Z http://eprints.uanl.mx/15810/ Eltrombopag, low‐dose rituximab, and dexamethasone combination as frontline treatment of newly diagnosed immune thrombocytopaenia Gómez Almaguer, David Colunga Pedraza, Perla Rocío Gómez de León, Andrés Gutiérrez Aguirre, César Homero Cantú Rodríguez, Olga Graciela Jaime Pérez, José Carlos 2019-12-21 Article PeerReviewed text en cc_by_nc_nd http://eprints.uanl.mx/15810/1/12.pdf http://eprints.uanl.mx/15810/1.haspreviewThumbnailVersion/12.pdf Gómez Almaguer, David y Colunga Pedraza, Perla Rocío y Gómez de León, Andrés y Gutiérrez Aguirre, César Homero y Cantú Rodríguez, Olga Graciela y Jaime Pérez, José Carlos (2019) Eltrombopag, low‐dose rituximab, and dexamethasone combination as frontline treatment of newly diagnosed immune thrombocytopaenia. British journal of haematology, 184 (2). pp. 288-290. ISSN 0007-1048 http://doi.org/10.1111/bjh.15070 doi:10.1111/bjh.15070 |
spellingShingle | Gómez Almaguer, David Colunga Pedraza, Perla Rocío Gómez de León, Andrés Gutiérrez Aguirre, César Homero Cantú Rodríguez, Olga Graciela Jaime Pérez, José Carlos Eltrombopag, low‐dose rituximab, and dexamethasone combination as frontline treatment of newly diagnosed immune thrombocytopaenia |
thumbnail | https://rediab.uanl.mx/themes/sandal5/images/online.png |
title | Eltrombopag, low‐dose rituximab, and dexamethasone combination as frontline treatment of newly diagnosed immune thrombocytopaenia |
title_full | Eltrombopag, low‐dose rituximab, and dexamethasone combination as frontline treatment of newly diagnosed immune thrombocytopaenia |
title_fullStr | Eltrombopag, low‐dose rituximab, and dexamethasone combination as frontline treatment of newly diagnosed immune thrombocytopaenia |
title_full_unstemmed | Eltrombopag, low‐dose rituximab, and dexamethasone combination as frontline treatment of newly diagnosed immune thrombocytopaenia |
title_short | Eltrombopag, low‐dose rituximab, and dexamethasone combination as frontline treatment of newly diagnosed immune thrombocytopaenia |
title_sort | eltrombopag low dose rituximab and dexamethasone combination as frontline treatment of newly diagnosed immune thrombocytopaenia |
url | http://eprints.uanl.mx/15810/1/12.pdf |
work_keys_str_mv | AT gomezalmaguerdavid eltrombopaglowdoserituximabanddexamethasonecombinationasfrontlinetreatmentofnewlydiagnosedimmunethrombocytopaenia AT colungapedrazaperlarocio eltrombopaglowdoserituximabanddexamethasonecombinationasfrontlinetreatmentofnewlydiagnosedimmunethrombocytopaenia AT gomezdeleonandres eltrombopaglowdoserituximabanddexamethasonecombinationasfrontlinetreatmentofnewlydiagnosedimmunethrombocytopaenia AT gutierrezaguirrecesarhomero eltrombopaglowdoserituximabanddexamethasonecombinationasfrontlinetreatmentofnewlydiagnosedimmunethrombocytopaenia AT canturodriguezolgagraciela eltrombopaglowdoserituximabanddexamethasonecombinationasfrontlinetreatmentofnewlydiagnosedimmunethrombocytopaenia AT jaimeperezjosecarlos eltrombopaglowdoserituximabanddexamethasonecombinationasfrontlinetreatmentofnewlydiagnosedimmunethrombocytopaenia |